Skip to content Skip to footer
Subscribe Now
MAGAZINE

PharmaShots Magazine-May-2026 Edition

Shots: PharmaShots’ May Edition explores how AI is transforming commercial strategies across the healthcare ecosystem by enabling predictive analytics, personalized engagement, dynamic launch planning, and real-time omnichannel optimization while balancing compliance and measurable ROI. The magazine highlights key industry movements shaping global biopharma, including AI-driven drug discovery collaborations, strategic M&A activity, advancements in cell and…
May 14, 2026

Read more

EVENTS

PharmaShots Awards 2026: Honoring Global Market Titans & Healthcare Innovators

• The PharmaShots Awards 2026 – Market Titans & Innovators represents a global celebration of healthcare innovation, establishing a strong benchmark by recognizing excellence across biopharma, medtech, diagnostics, generics, nutraceuticals, animal health, digital health, and AI-driven drug discovery while bringing the entire ecosystem onto one unified stage. • The awards honor industry leaders driving real…
May 6, 2026

Read more

MAGAZINE

PharmaShots Magazine-April-2026 Edition

Shots: AI is redefining compliance from reactive to predictive, as this April edition highlights how AI-powered systems are transforming regulatory oversight into a continuous, real-time, and data-driven function, enabling early risk detection, automated audits, and smarter regulatory collaboration across the pharma value chain. Strategic dealmaking and AI partnerships shape industry momentum, with March witnessing high-value…
April 9, 2026

Read more

CXO TALKS

PharmaShots CXO Talks | Women’s History Month Special: A Conversation with Dr. Emanuela Offidani of Tris Pharma

Shots: Dr. Emanuela Offidani explains how ADHD is increasingly recognized as a lifelong condition affecting both children and adults. She highlights that symptoms can differ across genders and are often underdiagnosed in women due to less visible hyperactivity and more internalized symptoms such as inattention and emotional dysregulation. The conversation explores how Tris Pharma is…
March 26, 2026

Read more

MAGAZINE

PharmaShots Magazine-March-2026 Edition

Shots AI is transforming clinical trial oversight from periodic monitoring to continuous, real-time intelligence, enabling early detection of safety signals, protocol deviations, and operational risks while strengthening data integrity and patient protection. Advanced analytics and machine learning are powering predictive, risk-based monitoring, integrating data from decentralized trials, wearables, ePROs, and multiple clinical systems to prioritize…
March 12, 2026

Read more

MAGAZINE

PharmaShots Magazine-February-2026 Edition

Shots: AI is moving drug development from computation to clinical confidence, showing how it now guides target discovery, molecule design, patient stratification, and trial planning while turning fragmented biomedical data into decision-ready insight that reduces risk, cost, and failure rates. Trust, transparency, and regulation define AI’s real breakthrough, as the focus shifts beyond speed toward…
February 12, 2026

Read more

MAGAZINE

PharmaShots Magazine-January-2026 Edition

Shots: Amid rising R&D costs and tighter timelines, AI has evolved from a supporting tool to a central driver of biopharma deal-making, discovery strategies, and long-term value creation AI-led licensing deals, platform partnerships, and new valuation models are reshaping biotech–pharma collaborations, with platforms and proprietary datasets increasingly rivaling or surpassing traditional pipelines in deal value…
January 15, 2026

Read more

MAGAZINE

PharmaShots Magazine-December-2025 Edition

In a healthcare environment defined by rapid scientific leaps and rising patient expectations, two influential forces are quietly reshaping the industry’s very foundation: Key Opinion Leaders (KOLs) and Patient Advocacy Groups (PAGs) Once background contributors, they have emerged as pivotal architects of modern healthcare, steering clinical decisions, shaping scientific narratives, influencing policy, and ensuring that patient voices are not just heard…
December 11, 2025

Read more

MAGAZINE

PharmaShots Magazine-November-2025 Edition

Radiopharmaceuticals, once viewed as a niche scientific endeavor, are now revolutionizing the way we detect and treat cancer. By fusing the targeting precision of molecular medicine with the therapeutic strength of radiation, these compounds are unlocking new possibilities in oncology, bringing renewed hope to patients where conventional therapies often fall short From early detection to…
November 13, 2025

Read more

Load more